{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:59:00Z","timestamp":1788969540594,"version":"build-2803163510"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Adult-onset Still's disease (AOSD) is a polygenic systemic autoinflammatory disease which is associated with increased morbidity and mortality. Pulmonary involvement is a rare, but serious complication of AOSD. As in AOSD, IL-1b, IL-18, and IL-6 dominate the molecular pathogenesis, which mediate a type 1 and type 3 inflammatory signature of the adaptive immune system. This is evidenced by the success of IL-1- and IL-6 inhibition in the management of AOSD. However, anaphylactic reactions to treatment with IL-1- or IL-6-inhibitors is currently being discussed as a potential trigger for lung involvement inf AOSD, while genetic risk factors have also been identified. Clinically, pulmonary involvement in AOSD can manifest in many different forms. Parenchymal inflammation with peripheral consolidations is the most frequent form while PAH is less common, but often very difficult to manage. This mini-review provides an overview of the pathophysiology as well as the clinical presentation and the diagnostic features of pulmonary involvement in AOSD.<\/jats:p>","DOI":"10.3389\/fmed.2022.989777","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T04:53:21Z","timestamp":1663304001000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review"],"prefix":"10.3389","volume":"9","author":[{"given":"Jasper F.","family":"Nies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00393-021-01117-w","volume":"81","author":"Regel","year":"2022","journal-title":"Z Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/art.41073","article-title":"Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors","volume":"71","author":"Schulert","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/03009740510026616","article-title":"Epidemiology and outcome of adult-onset Still's disease in Northern Norway","volume":"35","author":"Evensen","year":"2006","journal-title":"Scand J Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis."},{"key":"B6","first-page":"1608","article-title":"Still's disease in a 72-year-old man","volume":"20","author":"Uson","year":"1993","journal-title":"J Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","article-title":"Parenchymal lung involvement in adult-onset Still disease: a STROBE-compliant case series and literature review","volume":"95","author":"Gerfaud-Valentin","year":"2016","journal-title":"Medicine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13075-020-02245-5","article-title":"Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients","volume":"22","author":"Ruscitti","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"B9","first-page":"23","article-title":"Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse","volume":"121","author":"Takakuwa","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","article-title":"Emergent high fatality lung disease in systemic juvenile arthritis","volume":"78","author":"Saper","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"AB95","DOI":"10.1016\/j.jaci.2019.12.598","article-title":"Drug Reaction and High Fatality Lung Disease in Systemic Onset Juvenile Idiopathic Arthritis (sJIA)","volume":"145","author":"Saper","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/acr.21889","article-title":"Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis","volume":"65","author":"Kimura","year":"2013","journal-title":"Arthritis Care Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00393-021-01063-7","article-title":"Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab","volume":"81","author":"Zhang","year":"2022","journal-title":"Z Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.revmed.2013.02.014","volume":"35","author":"Liozon","year":"2014","journal-title":"Rev Med Interne."},{"key":"B18","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.3892\/mmr.2017.8275","article-title":"Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adultonset Still's disease","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Med Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"981232","DOI":"10.1155\/2013\/981232","article-title":"Adult onset still's disease: a case report with a rare clinical manifestation and pathophysiological correlations","volume":"2013","author":"Antoniou","year":"2013","journal-title":"Case Rep Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","article-title":"Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease","volume":"63","author":"Chen","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.1038\/srep46652","article-title":"Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3899\/jrheum.111500","article-title":"Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease","volume":"39","author":"Park","year":"2012","journal-title":"J Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","article-title":"Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/03008200903461462","article-title":"The associations of circulating CD4+CD25high regulatory T cells and TGF-beta with disease activity and clinical course in patients with adult-onset Still's disease","volume":"51","author":"Chen","year":"2010","journal-title":"Connect Tissue Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4193","article-title":"Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease","volume":"15","author":"Chen","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2169\/internalmedicine.53.1868","article-title":"rare case of diffuse pulmonary nodules in a patient with adult-onset Still's disease","volume":"53","author":"Qi","year":"2014","journal-title":"Intern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/pmj.78.916.97","article-title":"Adult Still's disease and respiratory failure in a 74 year old woman","volume":"78","author":"Stoica","year":"2002","journal-title":"Postgrad Med J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/blood-2014-05-575225","article-title":"T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung","volume":"125","author":"Iriguchi","year":"2015","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","article-title":"Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles","volume":"81","author":"Saper","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/S2665-9913(21)00072-2","article-title":"First manifestation of adult-onset Still's disease after COVID-19","volume":"3","author":"Bamidis","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.3346\/jkms.2021.36.e344","article-title":"Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci."},{"key":"B36","first-page":"2015","article-title":"Adult Still's disease. Still many issues unresolved","volume":"23","author":"Kahn","year":"1996","journal-title":"J Rheumatol."},{"key":"B37","first-page":"1599","article-title":"Adult Still's disease in only one of identical twins","volume":"16","author":"Brandwein","year":"1989","journal-title":"J Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine."},{"key":"B39","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin Exp Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4239","article-title":"A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease","volume":"15","author":"Wang","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3346\/jkms.2009.24.1.155","article-title":"A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage","volume":"24","author":"Sari","year":"2009","journal-title":"J Korean Med Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000050469","article-title":"Bilateral empyema caused by adult-onset Still's disease","volume":"68","author":"Mattiuzzo","year":"2001","journal-title":"Respiration."},{"key":"B43","article-title":"Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers","volume-title":"Arthritis Rheumatol.","author":"Chen","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/ard.42.4.452","article-title":"Adult-onset Still's disease with an associated severe restrictive pulmonary defect: a case report","volume":"42","author":"Corbett","year":"1983","journal-title":"Ann Rheum Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/a-1530-4247","article-title":"Lungenbeteiligung bei der systemischen juvenilen Arthritis","volume":"41","author":"Rolfes","year":"2021","journal-title":"Arthritis und Rheuma."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10067-006-0382-3","article-title":"Pulmonary hypertension in a patient with adult-onset stills disease","volume":"26","author":"Mubashir","year":"2007","journal-title":"Clin Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semarthrit.2018.11.007","article-title":"Pulmonary arterial hypertension in adult-onset Still's disease: a case series and systematic review of the literature","volume":"49","author":"Narvaez","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B48","first-page":"52","article-title":"OP0094 Pulmonary arterial hypertension in adult-onset still's disease: a case series of 13 patients","volume-title":"J Annals Rheum Dis.","author":"Mitrovic","year":"2021"},{"key":"B49","doi-asserted-by":"publisher","first-page":"0954406220913584","DOI":"10.1177\/2054270419894834","article-title":"case report of Adult-onset Still's disease presenting with acute fibrinous and organising pneumonia","volume":"11","author":"Perry","year":"2020","journal-title":"JRSM Open."},{"key":"B50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/LBR.0b013e3181bdab74","article-title":"Adult-onset Still's Disease With Pulmonary Involvement","volume":"16","author":"Hijikata","year":"2009","journal-title":"J Bronchology Interv Pulmonol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2169\/internalmedicine.50.4180","article-title":"A case of adult onset Still's disease complicated with cryptogenic organizing pneumonia","volume":"50","author":"Sato","year":"2011","journal-title":"Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","article-title":"How I treat patients with adult onset Still's disease in clinical practice","volume":"16","author":"Govoni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"537613","DOI":"10.1155\/2012\/537613","article-title":"Pulmonary arterial hypertension in adult-onset still's disease: rapid response to Anakinra","volume":"2012","author":"Campos","year":"2012","journal-title":"Case Rep Rheumatol."},{"key":"B54","first-page":"657","article-title":"Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease","volume":"31","author":"Padilla-Ibarra","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rmcr.2016.06.007","article-title":"Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15 years of follow-up","volume":"19","author":"Weatherald","year":"2016","journal-title":"Respir Med Case Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/14712598.2019.1652591","article-title":"Biologics for the treatment of adult-onset still's disease","volume":"19","author":"Yoo","year":"2019","journal-title":"Expert Opin Biol Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine."},{"key":"B58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.55563\/clinexprheumatol\/fsq5vq","article-title":"The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature","volume":"39","author":"Giacomelli","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8054961","DOI":"10.1155\/2020\/8054961","article-title":"Real-life data on the efficacy of canakinumab in patients with adult-onset still's disease","volume":"2020","author":"Vitale","year":"2020","journal-title":"Mediators Inflamm."},{"key":"B60","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3389\/fphar.2019.00918","article-title":"Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease","volume":"10","author":"Sota","year":"2019","journal-title":"Front Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.berh.2012.07.002","article-title":"Biological treatment in adult-onset Still's disease","volume":"26","author":"Pouchot","year":"2012","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","article-title":"Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial","volume":"77","author":"Kaneko","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"878797","DOI":"10.3389\/fmed.2022.878797","article-title":"Development and implementation of the AIDA international registry for patients with still's disease","volume":"9","author":"Vitale","year":"2022","journal-title":"Front Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"887","DOI":"10.21037\/atm-20-3127","article-title":"Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature","volume":"8","author":"Gabr","year":"2020","journal-title":"Ann Transl Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2019-216699","article-title":"Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China","volume":"79","author":"Hu","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/rheumatology\/key414","article-title":"Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy","volume":"58","author":"Ladhari","year":"2019","journal-title":"Rheumatology (Oxford)."},{"key":"B67","doi-asserted-by":"publisher","first-page":"930071","DOI":"10.3389\/fmed.2022.930071","article-title":"Effectiveness and safety of JAK inhibitors in autoinflammatory diseases: a systematic review","volume":"9","author":"Boyadzhieva","year":"2022","journal-title":"Front Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989777\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T04:53:36Z","timestamp":1663304016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989777\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":68,"alternative-id":["10.3389\/fmed.2022.989777"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.989777","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"989777"}}